Special Issue "Algal Research: From Cultivation to Drugs"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (1 July 2023) | Viewed by 6579
Interests: phycology; marine molecules; extraction eco-friendly processes; antiviral agents; SAR studies
Special Issues, Collections and Topics in MDPI journals
Special Issue in Metabolites: Seaweeds Metabolites
Special Issue in Marine Drugs: Invertebrate or Macroalgae-Associated Microbiome: A New Source of Bioactive Compounds with Therapeutical, Biotechnological Applications
Special Issue in Marine Drugs: Pharmacological Models and Assays in Marine Drugs Evaluation
Interests: marine biotechnology; marine ecology and physiology; algae; environmental biology; marine biodiversity; marine bioactive compounds; phycology
Marine algae are connected to their environment and confronted with different abiotic and biotic stresses. They are subject to the effects of light radiation, desiccation, salinity and temperature variations, nutrient supply, the impact of herbivores, and human activity. They are also engaged in competition for space and fight against microfouling and epiphytism. Large-scale biological screening experiments have highlighted the potential of bioactive metabolites present in extracts from marine organisms for applications in biotechnologies and the pharmaceutical, health, and wellness industry. For several decades, anti-inflammatory, antibiotic, antioxidant, antitumor, and antiviral properties were revealed.
In order to preserve natural resources, “moleculture” aims to develop techniques for obtaining metabolites from living organisms: aquaculture, marine invertebrate or microorganism culture, cell culture, synthetic biology, etc. However, are these “eco-friendly” processes economically viable? This Special Issue proposes to explore and promote research specifically targeting the culture of marine organisms, including their associated microbial communities toward metabolite production. Blue biotechnology, the biorefinery concept, aquaculture, microorganisms’ culture, cell culture, and omics methods combined with various analytical experimentations of purification and evaluation of biological activities may be proposed for publication on this topic.
Prof. Dr. Nathalie Bourgougnon
Dr. Daniel Robledo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.